How much funding has Replimune Group raised?

Replimune Group has raised $55.0M in total funding, most recently a Series B round.

Who are Replimune Group's investors?

Replimune Group's investors include Foresite Capital, Atlas Venture, Bain Capital Life Sciences, Sofinnova Partners, Omega Funds.

When was Replimune Group founded?

Replimune Group was founded in 2015.

Where is Replimune Group headquartered?

Replimune Group is headquartered in Woburn, Massachusetts, United States.

What industry is Replimune Group in?

Replimune Group operates in Biotech, Healthcare.

How many employees does Replimune Group have?

Replimune Group has 51-200 employees.

Replimune Group

IPO

Oncolytic Immunotherapies

Public · Woburn, United States · Founded 2015 · $55.0M raised

Biotech

Healthcare

Headquarters: Woburn, Massachusetts
Employees: 51–200
Founded: 2015
Business Model: B2B
Website: replimune.com

Total Funding: $55.0M
Last Round: $55.0M Series BSep 2017
Rounds: 3
Type: Public

About

Clinical-stage biotech company revolutionizing cancer treatment with a novel class of oncolytic immunotherapies based on an HSV-1 platform.

Summary

Replimune Group is a Biotech company based in Woburn, United States, founded in 2015. It has raised $55.0M in total across 3 rounds, most recently a $55.0M Series B round in Sep 2017. Investors include Foresite Capital, Atlas Venture and Bain Capital Life Sciences.

LinkedIn X (Twitter)